
Sign up to save your podcasts
Or


He sees an optimistic turn after a challenging couple of years. Plus, highlighting Vicor, Camurus, Oculis, and BioArctic.
By BiotechTV5
44 ratings
He sees an optimistic turn after a challenging couple of years. Plus, highlighting Vicor, Camurus, Oculis, and BioArctic.

30,626 Listeners

1,863 Listeners

1,085 Listeners

325 Listeners

6,059 Listeners

60 Listeners

9,840 Listeners

86 Listeners

34 Listeners

19 Listeners

260 Listeners

497 Listeners

0 Listeners

4 Listeners

2 Listeners

6 Listeners